Enzo Biochem Inc
(ENZB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 07/31
| 07-2006 | 04-2006 | 01-2006 | 10-2005 | 07-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -15,667 | -11,158 | -7,724 | -3,286 | 3,004 |
| Depreciation Amortization | 1,124 | 847 | 563 | 281 | 2,332 |
| Income taxes - deferred | 640 | 640 | 640 | 640 | 891 |
| Accounts receivable | -1,261 | -2,193 | -1,789 | -383 | -1,015 |
| Accounts payable and accrued liabilities | -1,110 | -633 | -765 | -582 | 322 |
| Other Working Capital | -2,901 | -2,266 | -3,642 | -1,242 | 1,388 |
| Other Operating Activity | 8,999 | 7,907 | 6,331 | 2,530 | 6,198 |
| Operating Cash Flow | $-10,176 | $-6,856 | $-6,386 | $-2,042 | $13,120 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 6,691 | 6,695 | 6,692 | 524 | 10,443 |
| PPE Investments | -4,227 | -1,249 | -948 | -197 | -1,276 |
| Other Investing Activity | 124 | -22 | -50 | -98 | -161 |
| Investing Cash Flow | $2,588 | $5,424 | $5,694 | $229 | $9,006 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -150 | N/A | N/A | N/A | -150 |
| Common Stock Issued | 611 | 363 | 73 | 74 | 506 |
| Financing Cash Flow | $461 | $363 | $73 | $74 | $356 |
| Beginning Cash Position | 76,981 | 76,981 | 76,981 | 76,981 | 54,499 |
| End Cash Position | 69,854 | 75,912 | 76,362 | 75,242 | 76,981 |
| Net Cash Flow | $-7,127 | $-1,069 | $-619 | $-1,739 | $22,482 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,176 | -6,856 | -6,386 | -2,042 | 13,120 |
| Capital Expenditure | -4,227 | -1,249 | -948 | -197 | -1,276 |
| Free Cash Flow | -14,403 | -8,105 | -7,334 | -2,239 | 11,844 |